Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy

Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy

US Patent 9877952 · Granted Jan 30, 2018

Estimated economic value: $8,287,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease2022
Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease2022
Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppr2020
Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppr2020
Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease2020
Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease2020
Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease2019
Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease2019
Dosage regimen for a PI-3 kinase inhibitor2019
Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation supre2019
Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation supre2019
Therapies for hematologic malignancies2018